<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04899492</url>
  </required_header>
  <id_info>
    <org_study_id>ICO-2020-14</org_study_id>
    <nct_id>NCT04899492</nct_id>
  </id_info>
  <brief_title>Evaluation of Different Smoking Cessation Protocols: Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy in Cancer Patients Scheduled for Surgery</brief_title>
  <acronym>RESPIRE</acronym>
  <official_title>Pilot Study in Cancer Patients Scheduled for Surgery Evaluating Different Smoking Cessation Protocols : Nicotine Replacement, Motivational Interviewing (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Cancerologie de l'Ouest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Cancer Institute, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Institut Cancerologie de l'Ouest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial offers support and assistance to patients wishing to quit smoking in order to&#xD;
      increase the success rate of smoking cessation and all the benefits associated with it.&#xD;
      Patients will be monitored by a tobacco specialist and will be able to benefit from one or&#xD;
      more therapies complementary to Nicotine Replacement Therapy (NRT): Motivational Interviewing&#xD;
      (MI), Cognitive Behavioural Therapy (CBT) or Hypnotherapy.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study RESPIRE is aiming to identify some interventions to be proposed as part of a&#xD;
      smoking cessation programme for smokers with cancer requiring surgical treatment and wishing&#xD;
      to stop smoking. We aim to compare different smoking cessation methods in addition to the&#xD;
      currently recommended treatments: Nicotine Replacement Therapy (NRT). These procedures are:&#xD;
      Cognitive Behavioural Therapy (CBT), Motivational Interviewing (MI) or hypnotherapy in order&#xD;
      to improve the success rate of smoking cessation in this specific population.&#xD;
&#xD;
      All patients wishing to be supported to stop smoking will be randomized and will be followed&#xD;
      by a tobacco specialist before and after surgery. They will receive NRT for 12 months.&#xD;
&#xD;
      Smoking assessment, exhaled CO measurement, questionnaires will be completed regularly to&#xD;
      assess depression, anxiety and quality of life during the 12 months.&#xD;
&#xD;
      Patients randomized in group 2 will receive 1 to 3 MI. Patients randomized in group 3 will&#xD;
      receive 1 to 3 MI and 6 CBT sessions by a psychotherapist.&#xD;
&#xD;
      Patients randomized in group 4 will receive 1 to 3 MI and at least 3 sessions oh&#xD;
      hypnotherapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 29, 2021</start_date>
  <completion_date type="Anticipated">September 2023</completion_date>
  <primary_completion_date type="Anticipated">September 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>pilot study, monocentric, prospective, randomization according to Zelen's design</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Testing the feasibility of smoking cessation interventions evaluated in French cancer patients undergoing surgery</measure>
    <time_frame>12 months</time_frame>
    <description>Number of patients who completed all planned sessions out of the total number of patients randomised to each group</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Evaluate the efficacy of the following interventions for smoking cessation in French cancer patients: MI, CBT and Hypnotherapy, combined with nicotine replacement therapy</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of patients with an exhaled Carbone Monoxide (CO) measurement &lt; 10 ppm at study visits.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the efficacy of the following interventions for smoking cessation in French cancer patients: MI, CBT and Hypnotherapy, combined with nicotine replacement therapy</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of patients reporting no smoking during the last 7 days before the visit.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the efficacy of the different interventions in reducing tobacco consumption</measure>
    <time_frame>12 months</time_frame>
    <description>Number of cigarettes smoked per day from baseline</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the efficacy of the different interventions in terms of continued abstinence since surgery</measure>
    <time_frame>12 months</time_frame>
    <description>Percentage of patients reporting no smoking since surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the reduction in side effects of oncological treatments after smoking cessation</measure>
    <time_frame>3 month</time_frame>
    <description>Report all Grade &gt; 1 side effects of oncology treatments up to 3 months after the end of treatment or the end of the study</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Estimate the decrease in surgical complications</measure>
    <time_frame>1 month</time_frame>
    <description>Report all surgical complications (Grade &gt; 1 according to Clavien Dindo classification) up to 1 month after surgery</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the efficacy of interventions on patient depression and anxiety</measure>
    <time_frame>12 months</time_frame>
    <description>Patient Depression and anxiety will be evaluated by using the Hospital Anxiety and Depression Scale (HADS)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Evaluate the efficacy of interventions on patient quality of life</measure>
    <time_frame>12 months</time_frame>
    <description>Patient quality of life will be evaluated by using the Quality of Life Questionnaire (QLQ-C30)</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Breast Cancer</condition>
  <condition>Gynecologic Cancer</condition>
  <condition>Digestive Cancer</condition>
  <condition>Melanoma</condition>
  <arm_group>
    <arm_group_label>Group 1:Nicotine Replacement Therapy (NRT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients enrolled in group 1 will receive a Nicotine Replacement Therapy (NRT) from the study entry to end of study</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2:Motivational Interviewing (MI)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients enrolled in group 2 will receive a Nicotine Replacement Therapy (NRT) from the study entry to end of study and 1 to 3 Motivational Interviewing (MI) after randomization</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3:Cognitive Behavioural Therapy (CBT)</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients enrolled in group 3 will receive a Nicotine Replacement Therapy (NRT) from the study entry to end of study and 1 to 3 Motivational Interviewing (MI) after randomization and 6 sessions of CBT after Motivational Interviewing up to 6 months after</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4: Hypnotherapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients enrolled in group 4 will receive a Nicotine Replacement Therapy (NRT) from the study entry to end of study and 1 to 3 Motivational Interviewing (MI) after randomization and about 3 sessions of hypnotherapy up to 6 months after</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Motivational Interviewing (MI)</intervention_name>
    <description>1 to 3 Motivational Interviewing (MI) should be performed after randomization by a psychotherapist</description>
    <arm_group_label>Group 2:Motivational Interviewing (MI)</arm_group_label>
    <arm_group_label>Group 3:Cognitive Behavioural Therapy (CBT)</arm_group_label>
    <arm_group_label>Group 4: Hypnotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Cognitive Behavioural Therapy (CBT)</intervention_name>
    <description>6 Cognitive Behavioural Therapy (CBT) sessions should be performed after motivational interviewing up to 6 months by a psychotherapist</description>
    <arm_group_label>Group 3:Cognitive Behavioural Therapy (CBT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Hypnotherapy</intervention_name>
    <description>About 3 Hypnotherapy sessions should be performed after motivational interviewing up to 6 months by a hypnotherapist</description>
    <arm_group_label>Group 4: Hypnotherapy</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Nicotine Replacement Therapy (NRT)</intervention_name>
    <description>All patients will receive Nicotine Replacement Therapy (NRT) from randomization up to 6 months</description>
    <arm_group_label>Group 1:Nicotine Replacement Therapy (NRT)</arm_group_label>
    <arm_group_label>Group 2:Motivational Interviewing (MI)</arm_group_label>
    <arm_group_label>Group 3:Cognitive Behavioural Therapy (CBT)</arm_group_label>
    <arm_group_label>Group 4: Hypnotherapy</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age ≥ 18 years.&#xD;
&#xD;
          -  Smoking patient: daily tobacco consumption.&#xD;
&#xD;
          -  Patient with cancer requiring surgical treatment (breast cancer, digestive cancer,&#xD;
             gynecological).&#xD;
&#xD;
          -  Patient wishing to quit smoking.&#xD;
&#xD;
          -  Fagerström &gt; 3.&#xD;
&#xD;
          -  Patient has valid health insurance&#xD;
&#xD;
          -  Information and agreement of the patient to participate in the longitudinal cohort.&#xD;
&#xD;
          -  Signing of specific informed consent for patients in groups 1 to 4 before any&#xD;
             study-related intervention.&#xD;
&#xD;
          -  Person able to speak, read and understand French.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patient not receiving surgical treatment.&#xD;
&#xD;
          -  Refusal to participate in the longitudinal cohort study.&#xD;
&#xD;
          -  Pregnant or likely to be pregnant or nursing patient.&#xD;
&#xD;
          -  Persons deprived of their liberty, under a measure of safeguard of justice, under&#xD;
             guardianship or placed under the authority of a guardian&#xD;
&#xD;
          -  disability to undergo the medical follow-up of the trial for geographical, social or&#xD;
             psychological reasons.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Charlotte BOURGIN, MD</last_name>
    <phone>+33 2 40 67 99 00</phone>
    <email>charolotte.bourgin@ico.unicancer.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Nadia ALLAM, PhD</last_name>
    <phone>+ 33 2 40 67 98 26</phone>
    <email>nadia.allam@ico.unicancer.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Institut de Cancerologie de l'Ouest (ICO)</name>
      <address>
        <city>Saint-Herblain</city>
        <zip>44805</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Charlotte BOURGIN, MD</last_name>
      <phone>+33 2 40 67 99 00</phone>
      <email>charlotte.bourgin@ico.unicancer.fr</email>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 19, 2021</study_first_submitted>
  <study_first_submitted_qc>May 19, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 24, 2021</study_first_posted>
  <last_update_submitted>October 15, 2021</last_update_submitted>
  <last_update_submitted_qc>October 15, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Smoking Cessation</keyword>
  <keyword>Motivational Interviewing (MI)</keyword>
  <keyword>Cognitive Behavioural Therapy (CBT)</keyword>
  <keyword>Hypnotherapy</keyword>
  <keyword>Nicotine Replacement Therapy (NRT)</keyword>
  <keyword>Surgery</keyword>
  <keyword>Surgery complications</keyword>
  <keyword>longitudinal cohort</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Melanoma</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nicotine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

